149 related articles for article (PubMed ID: 18415064)
1. [Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma].
Naim R
HNO; 2008 May; 56(5):490-2. PubMed ID: 18415064
[No Abstract] [Full Text] [Related]
2. Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study.
Tan IB; Dolivet G; Ceruse P; Vander Poorten V; Roest G; Rauschning W
Head Neck; 2010 Dec; 32(12):1597-604. PubMed ID: 20848401
[TBL] [Abstract][Full Text] [Related]
3. [Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].
Lorenz KJ; Maier H
HNO; 2008 Apr; 56(4):402-9. PubMed ID: 17516041
[TBL] [Abstract][Full Text] [Related]
4. Endoluminal tracheal stenting prior to head and neck PDT.
Algharib AM; Sultan A; Parekh J; Vaz F; Hopper C
Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):444-6. PubMed ID: 24792454
[No Abstract] [Full Text] [Related]
5. mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.
de Visscher SA; Dijkstra PU; Tan IB; Roodenburg JL; Witjes MJ
Oral Oncol; 2013 Mar; 49(3):192-210. PubMed ID: 23068024
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.
Lorenz KJ; Maier H
Eur Arch Otorhinolaryngol; 2009 Dec; 266(12):1937-44. PubMed ID: 19290535
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
Savary JF; Monnier P; Fontolliet C; Mizeret J; Wagnières G; Braichotte D; van den Bergh H
Arch Otolaryngol Head Neck Surg; 1997 Feb; 123(2):162-8. PubMed ID: 9046283
[TBL] [Abstract][Full Text] [Related]
8. Treatment of head and neck cancer with photodynamic therapy: results after one year.
Dilkes MG; DeJode ML; Gardiner Q; Kenyon GS; McKelvie P
J Laryngol Otol; 1995 Nov; 109(11):1072-6. PubMed ID: 8551123
[TBL] [Abstract][Full Text] [Related]
9. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
Kübler AC; de Carpentier J; Hopper C; Leonard AG; Putnam G
Int J Oral Maxillofac Surg; 2001 Dec; 30(6):504-9. PubMed ID: 11829232
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.
Separovic D; Bielawski J; Pierce JS; Merchant S; Tarca AL; Bhatti G; Ogretmen B; Korbelik M
Int J Oncol; 2011 Feb; 38(2):521-7. PubMed ID: 21152858
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.
Kübler AC; Haase T; Staff C; Kahle B; Rheinwald M; Mühling J
Lasers Surg Med; 1999; 25(1):60-8. PubMed ID: 10421887
[TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.
Hopper C; Niziol C; Sidhu M
Oral Oncol; 2004 Apr; 40(4):372-82. PubMed ID: 14969816
[TBL] [Abstract][Full Text] [Related]
13. Ray of light for treatment of head and neck cancer.
Morris K
Lancet Oncol; 2000 Sep; 1(1):10. PubMed ID: 11905675
[No Abstract] [Full Text] [Related]
14. Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases.
Dilkes MG; Benjamin E; Ovaisi S; Banerjee AS
J Laryngol Otol; 2003 Sep; 117(9):713-7. PubMed ID: 14561360
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Reuther T; Kübler AC; Zillmann U; Flechtenmacher C; Sinn H
Lasers Surg Med; 2001; 29(4):314-22. PubMed ID: 11746108
[TBL] [Abstract][Full Text] [Related]
16. Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29.
Korbelik M; Zhang W; Separovic D
Lasers Surg Med; 2011 Sep; 43(7):614-20. PubMed ID: 22057489
[TBL] [Abstract][Full Text] [Related]
17. Meta-tetrahydroxyphenyl chlorine mediated photodynamic therapy inhibits the migration and invasion of a nasopharyngeal carcinoma KJ-1 cell line.
Wang CP; Lou PJ; Lo FY; Shieh MJ
J Formos Med Assoc; 2014 Mar; 113(3):173-8. PubMed ID: 24630035
[TBL] [Abstract][Full Text] [Related]
18. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Horlings RK; Terra JB; Witjes MJ
Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858
[TBL] [Abstract][Full Text] [Related]
19. Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy.
Bovis MJ; Woodhams JH; Loizidou M; Scheglmann D; Bown SG; Macrobert AJ
J Control Release; 2012 Jan; 157(2):196-205. PubMed ID: 21982898
[TBL] [Abstract][Full Text] [Related]
20. Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
Buchholz J; Kaser-Hotz B; Khan T; Rohrer Bley C; Melzer K; Schwendener RA; Roos M; Walt H
Clin Cancer Res; 2005 Oct; 11(20):7538-44. PubMed ID: 16243829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
